Compare stocks

Santhera Pharmaceuticals Holding AG is a Swiss pharmaceutical company focused on the development and commercialization of innovative treatments for rare and debilitating diseases. The company's key areas of expertise include neuromuscular and pulmonary disorders. Santhera's product pipeline features several investigational drugs targeting conditions such as Duchenne muscular dystrophy and cystic fibrosis. Headquartered in Pratteln, Switzerland, the company leverages its scientific expertise and industry partnerships to advance its therapeutic offerings. Santhera's strategic focus on niche markets allows it to address unmet medical needs, providing potential opportunities for growth within specialized segments of the healthcare industry.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.